L-threo-L-ido-Nononic acid, O-2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl-(1→3)-O-[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl-(1→5)]-2,4,7,8,9-pentadeoxy-2,4,8-trimethyl-6-C-methyl-9-[methyl(1,2,6,7-tetradeoxy-4-C-methyl-D-manno-heptitol-2-yl)amino]-

L-threo-L-ido-Nononic acid, O-2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl-(1→3)-O-[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl-(1→5)]-2,4,7,8,9-pentadeoxy-2,4,8-trimethyl-6-C-methyl-9-[methyl(1,2,6,7-tetradeoxy-4-C-methyl-D-manno-heptitol-2-yl)amino]- Struktur
2365312-75-8
CAS-Nr.
2365312-75-8
Englisch Name:
L-threo-L-ido-Nononic acid, O-2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl-(1→3)-O-[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl-(1→5)]-2,4,7,8,9-pentadeoxy-2,4,8-trimethyl-6-C-methyl-9-[methyl(1,2,6,7-tetradeoxy-4-C-methyl-D-manno-heptitol-2-yl)amino]-
Synonyma:
Alogliptin Impurity 93;L-threo-L-ido-Nononic acid, O-2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl-(1→3)-O-[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl-(1→5)]-2,4,7,8,9-pentadeoxy-2,4,8-trimethyl-6-C-methyl-9-[methyl(1,2,6,7-tetradeoxy-4-C-methyl-D-manno-heptitol-2-yl)amino]-
CBNumber:
CB19821416
Summenformel:
C38H74N2O13
Molgewicht:
767.01
MOL-Datei:
2365312-75-8.mol

L-threo-L-ido-Nononic acid, O-2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl-(1→3)-O-[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl-(1→5)]-2,4,7,8,9-pentadeoxy-2,4,8-trimethyl-6-C-methyl-9-[methyl(1,2,6,7-tetradeoxy-4-C-methyl-D-manno-heptitol-2-yl)amino]- Eigenschaften

Siedepunkt:
855.3±65.0 °C(Predicted)
Dichte
1.19±0.1 g/cm3(Predicted)
pka
4.19±0.27(Predicted)

Sicherheit

L-threo-L-ido-Nononic acid, O-2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl-(1→3)-O-[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl-(1→5)]-2,4,7,8,9-pentadeoxy-2,4,8-trimethyl-6-C-methyl-9-[methyl(1,2,6,7-tetradeoxy-4-C-methyl-D-manno-heptitol-2-yl)amino]- Chemische Eigenschaften,Einsatz,Produktion Methoden

L-threo-L-ido-Nononic acid, O-2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl-(1→3)-O-[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl-(1→5)]-2,4,7,8,9-pentadeoxy-2,4,8-trimethyl-6-C-methyl-9-[methyl(1,2,6,7-tetradeoxy-4-C-methyl-D-manno-heptitol-2-yl)amino]- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


L-threo-L-ido-Nononic acid, O-2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl-(1→3)-O-[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl-(1→5)]-2,4,7,8,9-pentadeoxy-2,4,8-trimethyl-6-C-methyl-9-[methyl(1,2,6,7-tetradeoxy-4-C-methyl-D-manno-heptitol-2-yl)amino]- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 4)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hubei Yangxin Medical Technology Co., Ltd. 15374522761
3003392093@qq.com China 7851 55
Jinan blalong chemical co. LTD 2710913286@.com
1513643261@qq.com China 14253 58
Shanghai Zerui Biotechnology Co., Ltd. 021-54580889 18321124657
731997554@qq.com China 10614 58
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd 18162595016
3287908757@qq.com China 9886 58

  • L-threo-L-ido-Nononic acid, O-2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl-(1→3)-O-[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl-(1→5)]-2,4,7,8,9-pentadeoxy-2,4,8-trimethyl-6-C-methyl-9-[methyl(1,2,6,7-tetradeoxy-4-C-methyl-D-manno-heptitol-2-yl)amino]-
  • Alogliptin Impurity 93
  • 2365312-75-8
Copyright 2019 © ChemicalBook. All rights reserved